抗うつ薬の世界市場動向・分析2018-2025

【英語タイトル】Global Antidepressants Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D00484)・商品コード:QYR8D00484
・発行会社(調査会社):QYResearch
・発行日:2018年12月7日(※2024年版があります。お問い合わせください)
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、抗うつ薬の世界市場について調査・分析し、種類別には、三環系抗うつ薬、選択的セロトニン再取込阻害薬、選択的ノルエピネフリン再取込阻害薬、モノアミン酸化酵素阻害薬、ベンゾジアゼピン、抗精神病薬、新薬に、用途別には、病院、クリニック、その他に区分してまとめました。調査対象企業は、H Lundbeck、Astrazeneca、Eli Lilly and Company、Sun Pharmaceuticals、Pfizer Inc.、GlaxoSmithKline、Bristol-Myers Squibb Company、Johnson & Johnson、Merck、Sanofi等です。

・レポートの概要
・グローバル成長トレンド
・抗うつ薬の世界市場規模
・抗うつ薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別抗うつ薬の価格動向
・抗うつ薬の種類別市場規模(三環系抗うつ薬、選択的セロトニン再取込阻害薬、選択的ノルエピネフリン再取込阻害薬、モノアミン酸化酵素阻害薬、ベンゾジアゼピン、抗精神病薬、新薬)
・抗うつ薬の用途別市場規模(病院、クリニック、その他)
・抗うつ薬の北米市場(アメリカ、カナダ、メキシコ)
・抗うつ薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・抗うつ薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・抗うつ薬の中南米市場(ブラジル等)
・抗うつ薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(H Lundbeck、Astrazeneca、Eli Lilly and Company、Sun Pharmaceuticals、Pfizer Inc.、GlaxoSmithKline、Bristol-Myers Squibb Company、Johnson & Johnson、Merck、Sanofi)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・抗うつ薬の市場規模予測
・抗うつ薬の種類別市場予測2018-2025(三環系抗うつ薬、選択的セロトニン再取込阻害薬、選択的ノルエピネフリン再取込阻害薬、モノアミン酸化酵素阻害薬、ベンゾジアゼピン、抗精神病薬、新薬)
・抗うつ薬の用途別市場予測2018-2025(病院、クリニック、その他)
・抗うつ薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・抗うつ薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・抗うつ薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・抗うつ薬の中南米市場予測2018-2025(ブラジル等)
・抗うつ薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

In 2018, the global Antidepressants market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Antidepressants.
This study researches the market size of Antidepressants, presents the global Antidepressants sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Antidepressants in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Antidepressants for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
H Lundbeck
Astrazeneca
Eli Lilly and Company
Sun Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
Sanofi

Market Segment by Product Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Selective Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Benzodiazepines
Antipsychotics
Novel Agents

Market Segment by Application
Hospitals
Clinics
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Antidepressants status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Antidepressants manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antidepressants are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antidepressants Market Size Growth Rate by Type
1.3.2 Tricyclic Antidepressants
1.3.3 Selective Serotonin Reuptake Inhibitors
1.3.4 Selective Norepinephrine Reuptake Inhibitors
1.3.5 Monoamine Oxidase Inhibitors
1.3.6 Benzodiazepines
1.3.7 Antipsychotics
1.3.8 Novel Agents
1.4 Market Segment by Application
1.4.1 Global Antidepressants Market Share by Application (2018-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Antidepressants Market Size
2.1.1 Global Antidepressants Revenue 2013-2025
2.1.2 Global Antidepressants Sales 2013-2025
2.2 Antidepressants Growth Rate by Regions
2.2.1 Global Antidepressants Sales by Regions 2013-2018
2.2.2 Global Antidepressants Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Antidepressants Sales by Manufacturers
3.1.1 Antidepressants Sales by Manufacturers 2013-2018
3.1.2 Antidepressants Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Antidepressants Revenue by Manufacturers (2013-2018)
3.2.2 Antidepressants Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Antidepressants Market Concentration Ratio (CR5 and HHI)
3.3 Antidepressants Price by Manufacturers
3.4 Key Manufacturers Antidepressants Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antidepressants Market
3.6 Key Manufacturers Antidepressants Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Tricyclic Antidepressants Sales and Revenue (2013-2018)
4.1.2 Selective Serotonin Reuptake Inhibitors Sales and Revenue (2013-2018)
4.1.3 Selective Norepinephrine Reuptake Inhibitors Sales and Revenue (2013-2018)
4.1.4 Monoamine Oxidase Inhibitors Sales and Revenue (2013-2018)
4.1.5 Benzodiazepines Sales and Revenue (2013-2018)
4.1.6 Antipsychotics Sales and Revenue (2013-2018)
4.1.7 Novel Agents Sales and Revenue (2013-2018)
4.2 Global Antidepressants Sales Market Share by Type
4.3 Global Antidepressants Revenue Market Share by Type
4.4 Antidepressants Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Antidepressants Sales by Application

6 North America
6.1 North America Antidepressants Breakdown Data by Company
6.2 North America Antidepressants Breakdown Data by Type
6.3 North America Antidepressants Breakdown Data by Application
6.4 North America Antidepressants Breakdown Data by Countries
6.4.1 North America Antidepressants Sales by Countries
6.4.2 North America Antidepressants Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Antidepressants Breakdown Data by Company
7.2 Europe Antidepressants Breakdown Data by Type
7.3 Europe Antidepressants Breakdown Data by Application
7.4 Europe Antidepressants Breakdown Data by Countries
7.4.1 Europe Antidepressants Sales by Countries
7.4.2 Europe Antidepressants Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Antidepressants Breakdown Data by Company
8.2 Asia Pacific Antidepressants Breakdown Data by Type
8.3 Asia Pacific Antidepressants Breakdown Data by Application
8.4 Asia Pacific Antidepressants Breakdown Data by Countries
8.4.1 Asia Pacific Antidepressants Sales by Countries
8.4.2 Asia Pacific Antidepressants Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Antidepressants Breakdown Data by Company
9.2 Central & South America Antidepressants Breakdown Data by Type
9.3 Central & South America Antidepressants Breakdown Data by Application
9.4 Central & South America Antidepressants Breakdown Data by Countries
9.4.1 Central & South America Antidepressants Sales by Countries
9.4.2 Central & South America Antidepressants Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Antidepressants Breakdown Data by Type
10.2 Middle East and Africa Antidepressants Breakdown Data by Application
10.3 Middle East and Africa Antidepressants Breakdown Data by Countries
10.3.1 Middle East and Africa Antidepressants Sales by Countries
10.3.2 Middle East and Africa Antidepressants Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 H Lundbeck
11.1.1 H Lundbeck Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Antidepressants
11.1.4 Antidepressants Product Introduction
11.1.5 H Lundbeck Recent Development
11.2 Astrazeneca
11.2.1 Astrazeneca Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Antidepressants
11.2.4 Antidepressants Product Introduction
11.2.5 Astrazeneca Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Antidepressants
11.3.4 Antidepressants Product Introduction
11.3.5 Eli Lilly and Company Recent Development
11.4 Sun Pharmaceuticals
11.4.1 Sun Pharmaceuticals Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Antidepressants
11.4.4 Antidepressants Product Introduction
11.4.5 Sun Pharmaceuticals Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Antidepressants
11.5.4 Antidepressants Product Introduction
11.5.5 Pfizer Inc. Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Antidepressants
11.6.4 Antidepressants Product Introduction
11.6.5 GlaxoSmithKline Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Antidepressants
11.7.4 Antidepressants Product Introduction
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Antidepressants
11.8.4 Antidepressants Product Introduction
11.8.5 Johnson & Johnson Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Antidepressants
11.9.4 Antidepressants Product Introduction
11.9.5 Merck Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Antidepressants
11.10.4 Antidepressants Product Introduction
11.10.5 Sanofi Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Antidepressants Sales Channels
12.2.2 Antidepressants Distributors
12.3 Antidepressants Customers

13 Market Forecast
13.1 Global Antidepressants Sales and Revenue Forecast 2018-2025
13.2 Global Antidepressants Sales Forecast by Type
13.3 Global Antidepressants Sales Forecast by Application
13.4 Antidepressants Forecast by Regions
13.4.1 Global Antidepressants Sales Forecast by Regions 2018-2025
13.4.2 Global Antidepressants Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Antidepressants Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Antidepressants Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Antidepressants Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Antidepressants Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Antidepressants Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Antidepressants Product Picture
Table Antidepressants Key Market Segments
Table Major Manufacturers Antidepressants Covered in This Report
Table Global Antidepressants Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Antidepressants Sales Market Shar by Type 2013-2025
Figure Tricyclic Antidepressants Figures
Table Major Manufacturers of Tricyclic Antidepressants
Figure Selective Serotonin Reuptake Inhibitors Figures
Table Major Manufacturers of Selective Serotonin Reuptake Inhibitors
Figure Selective Norepinephrine Reuptake Inhibitors Figures
Table Major Manufacturers of Selective Norepinephrine Reuptake Inhibitors
Figure Monoamine Oxidase Inhibitors Figures
Table Major Manufacturers of Monoamine Oxidase Inhibitors
Figure Benzodiazepines Figures
Table Major Manufacturers of Benzodiazepines
Figure Antipsychotics Figures
Table Major Manufacturers of Antipsychotics
Figure Novel Agents Figures
Table Major Manufacturers of Novel Agents
Table Global Antidepressants Market Share by Application 2018-2025 (K Units)
Figure Hospitals Use Case
Figure Clinics Use Case
Figure Other Use Case
Figure Antidepressants Report Years Considered
Figure Global Antidepressants Market Size 2013-2025 (Million US$)
Figure Global Antidepressants Sales 2013-2018 (K Units)
Table Global Antidepressants Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Antidepressants Sales by Regions 2013-2018 (K Units)
Table Global Antidepressants Sales Market Share by Regions 2013-2018
Figure Global Antidepressants Sales Market Share by Regions 2013-2018
Figure Global Antidepressants Sales Market Share by Regions in 2018
Table Global Antidepressants Revenue by Regions 2013-2018 (Million US$)
Table Global Antidepressants Revenue Market Share by Regions 2013-2018
Figure Global Antidepressants Revenue Market Share by Regions 2013-2018
Figure Global Antidepressants Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Antidepressants Sales by Manufacturers (2013-2018) (K Units)
Table Global Antidepressants Sales Share by Manufacturers (2013-2018)
Figure Global Antidepressants Sales Share by Manufacturers in 2018
Table Antidepressants Revenue by Manufacturers (2013-2018) (Million USD)
Table Antidepressants Revenue Share by Manufacturers (2013-2018)
Figure Antidepressants Value Share by Manufacturers in 2018
Table Global Antidepressants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Antidepressants Price (2013-2018) (USD/Unit)
Table Key Manufacturers Antidepressants Plants/Factories Distribution
Table Key Manufacturers Antidepressants Area Served
Table Date of Key Manufacturers Enter into Antidepressants Market
Table Key Manufacturers Antidepressants Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Tricyclic Antidepressants Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Selective Serotonin Reuptake Inhibitors Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Selective Norepinephrine Reuptake Inhibitors Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Monoamine Oxidase Inhibitors Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Benzodiazepines Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Antipsychotics Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Novel Agents Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Antidepressants Sales by Type (2013-2018) (K Units)
Table Global Antidepressants Sales Share by Type (2013-2018)
Figure Global Antidepressants Sales Market Share by Type (2013-2018)
Figure Global Antidepressants Sales Market Share by Type in 2017
Table Global Antidepressants Revenue by Type (2013-2018) (Million US$)
Table Global Antidepressants Revenue Share by Type (2013-2018)
Figure Global Antidepressants Revenue Market Share by Type (2013-2018)
Figure Global Antidepressants Revenue Market Share by Type in 2017
Table Antidepressants Price by Type 2013-2018 (USD/Unit)
Table Global Antidepressants Sales by Application (2013-2018) (K Units)
Table Global Antidepressants Sales Share by Application (2013-2018)
Figure Global Sales Antidepressants Market Share by Application (2013-2018)
Figure Global Sales Antidepressants Market Share by Application in 2017
Figure North America Antidepressants Sales Growth Rate 2013-2018 (K Units)
Figure North America Antidepressants Revenue Growth Rate 2013-2018 (Million US$)
Table North America Antidepressants Sales by Company (2013-2018) (K Units)
Table North America Antidepressants Sales Market Share by Company (2013-2018)
Figure North America Antidepressants Sales Market Share by Company in 2018
Table North America Antidepressants Sales by Type (2013-2018) (K Units)
Table North America Antidepressants Sales Market Share by Type (2013-2018)
Figure North America Antidepressants Market Share by Type in 2018
Table North America Antidepressants Sales by Application (2013-2018) (K Units)
Table North America Antidepressants Sales Market Share by Application (2013-2018)
Figure North America Antidepressants Market Share by Application in 2018
Table North America Antidepressants Sales by Countries (2013-2018) (K Units)
Table North America Antidepressants Sales Market Share by Countries (2013-2018)
Figure 2017 North America Antidepressants Sales Market Share by Countries
Table North America Antidepressants Revenue by Countries (2013-2018) (Million US$)
Table North America Antidepressants Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Antidepressants Revenue Market Share by Countries
Figure United States Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Canada Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Europe Antidepressants Sales Growth Rate 2013-2018 (K Units)
Figure Europe Antidepressants Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Antidepressants Sales by Company (2013-2018) (K Units)
Table Europe Antidepressants Sales Market Share by Company (2013-2018)
Figure Europe Antidepressants Sales Market Share by Company in 2018
Table Europe Antidepressants Sales by Type (2013-2018) (K Units)
Table Europe Antidepressants Sales Market Share by Type (2013-2018)
Figure 2017 Europe Antidepressants Market Share by Type
Table Europe Antidepressants Sales by Application (2013-2018) (K Units)
Table Europe Antidepressants Sales Market Share by Application (2013-2018)
Figure 2017 Europe Antidepressants Market Share by Application
Table Europe Antidepressants Sales by Countries (2013-2018) (K Units)
Table Europe Antidepressants Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Antidepressants Sales Market Share by Countries
Table Europe Antidepressants Revenue by Countries (2013-2018) (Million US$)
Table Europe Antidepressants Revenue Market Share by Countries (2013-2018)
Figure Europe Antidepressants Revenue Market Share by Countries in 2018
Figure Germany Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure France Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure UK Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Italy Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Russia Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Antidepressants Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Antidepressants Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Antidepressants Sales by Company (2013-2018) (K Units)
Table Asia Pacific Antidepressants Sales Market Share by Company (2013-2018)
Figure Asia Pacific Antidepressants Sales Market Share by Company in 2018
Table Asia Pacific Antidepressants Sales by Type (2013-2018) (K Units)
Table Asia Pacific Antidepressants Sales Market Share by Type (2013-2018)
Figure Asia Pacific Antidepressants Market Share by Type in 2018
Table Asia Pacific Antidepressants Sales by Application (2013-2018) (K Units)
Table Asia Pacific Antidepressants Sales Market Share by Application (2013-2018)
Figure Asia Pacific Antidepressants Market Share by Application in 2018
Table Asia Pacific Antidepressants Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Antidepressants Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antidepressants Sales Market Share by Countries
Table Asia Pacific Antidepressants Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Antidepressants Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antidepressants Revenue Market Share by Countries
Figure China Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure China Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Japan Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Korea Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure India Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure India Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Australia Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Antidepressants Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Antidepressants Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Antidepressants Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Antidepressants Sales by Company (2013-2018) (K Units)
Table Central & South America Antidepressants Sales Market Share by Company (2013-2018)
Figure Central & South America Antidepressants Sales Market Share by Company in 2018
Table Central & South America Antidepressants Sales by Type (2013-2018) (K Units)
Table Central & South America Antidepressants Sales Market Share by Type (2013-2018)
Figure Central & South America Antidepressants Market Share by Type in 2018
Table Central & South America Antidepressants Sales by Application (2013-2018) (K Units)
Table Central & South America Antidepressants Sales Market Share by Application (2013-2018)
Figure Central & South America Antidepressants Market Share by Application in 2018
Table Central & South America Antidepressants Sales by Countries (2013-2018) (K Units)
Table Central & South America Antidepressants Sales Market Share by Countries (2013-2018)
Figure Central & South America Antidepressants Sales Market Share by Countries in 2018
Table Central & South America Antidepressants Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Antidepressants Revenue Market Share by Countries (2013-2018)
Figure Central & South America Antidepressants Revenue Market Share by Countries in 2018
Figure Brazil Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Antidepressants Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Antidepressants Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Antidepressants Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Antidepressants Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Antidepressants Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Antidepressants Market Share by Type
Table Middle East and Africa Antidepressants Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Antidepressants Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Antidepressants Market Share by Application
Table Middle East and Africa Antidepressants Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Antidepressants Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antidepressants Sales Market Share by Countries
Table Middle East and Africa Antidepressants Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Antidepressants Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antidepressants Revenue Market Share by Countries
Figure GCC Countries Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Antidepressants Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Antidepressants Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Antidepressants Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Antidepressants Revenue Growth Rate (2013-2018) (K Units)
Table H Lundbeck Company Details
Table H Lundbeck Description and Business Overview
Table H Lundbeck Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table H Lundbeck Antidepressants Sales Growth Rate (2013-2018)
Table H Lundbeck Antidepressants Sales Market Share in Global Market
Table H Lundbeck Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Description and Business Overview
Table Astrazeneca Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Astrazeneca Antidepressants Sales Growth Rate (2013-2018)
Table Astrazeneca Antidepressants Sales Market Share in Global Market
Table Astrazeneca Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Eli Lilly and Company Antidepressants Sales Growth Rate (2013-2018)
Table Eli Lilly and Company Antidepressants Sales Market Share in Global Market
Table Eli Lilly and Company Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Description and Business Overview
Table Sun Pharmaceuticals Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sun Pharmaceuticals Antidepressants Sales Growth Rate (2013-2018)
Table Sun Pharmaceuticals Antidepressants Sales Market Share in Global Market
Table Sun Pharmaceuticals Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Description and Business Overview
Table Pfizer Inc. Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Inc. Antidepressants Sales Growth Rate (2013-2018)
Table Pfizer Inc. Antidepressants Sales Market Share in Global Market
Table Pfizer Inc. Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table GlaxoSmithKline Antidepressants Sales Growth Rate (2013-2018)
Table GlaxoSmithKline Antidepressants Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Description and Business Overview
Table Bristol-Myers Squibb Company Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bristol-Myers Squibb Company Antidepressants Sales Growth Rate (2013-2018)
Table Bristol-Myers Squibb Company Antidepressants Sales Market Share in Global Market
Table Bristol-Myers Squibb Company Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Johnson & Johnson Antidepressants Sales Growth Rate (2013-2018)
Table Johnson & Johnson Antidepressants Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck Antidepressants Sales Growth Rate (2013-2018)
Table Merck Antidepressants Sales Market Share in Global Market
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Antidepressants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sanofi Antidepressants Sales Growth Rate (2013-2018)
Table Sanofi Antidepressants Sales Market Share in Global Market
Table Sanofi Recent Development
Figure Antidepressants Value Chain
Table Antidepressants Distributors List
Table Antidepressants Customers List
Table Global Antidepressants Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Global Antidepressants Revenue Forecast 2018-2025 (Million US$)
Table Global Antidepressants Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antidepressants Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antidepressants Sales Market Share Forecast by Type 2018-2025
Table Global Antidepressants Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antidepressants Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antidepressants Sales Market Share Forecast by Application 2018-2025
Table Global Antidepressants Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antidepressants Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antidepressants Sales Market Share Forecast by Regions 2018-2025
Table Global Antidepressants Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antidepressants Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antidepressants Revenue Market Share Forecast by Regions 2018-2025
Table North America Antidepressants Sales Forecast by Countries 2018-2025 (K Units)
Table North America Antidepressants Sales Market Share Forecast by Countries 2018-2025
Table North America Antidepressants Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Antidepressants Revenue Market Share Forecast by Countries 2018-2025
Figure United States Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Canada Antidepressants Sales Forecast 2018-2025 (K Units)
Figure MexicoAntidepressants Sales Forecast 2018-2025 (K Units)
Table Europe Antidepressants Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Antidepressants Sales Market Share Forecast by Countries 2018-2025
Table Europe Antidepressants Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Antidepressants Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Antidepressants Sales Forecast 2018-2025 (K Units)
Figure France Antidepressants Sales Forecast 2018-2025 (K Units)
Figure UK Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Italy Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Russia Antidepressants Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Antidepressants Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Antidepressants Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Antidepressants Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Antidepressants Revenue Market Share Forecast by Countries 2018-2025
Figure China Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Japan Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Korea Antidepressants Sales Forecast 2018-2025 (K Units)
Figure India Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Australia Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Indonesia Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Thailand Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Malaysia Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Philippines Antidepressants Sales Forecast 2018-2025 (K Units)
Figure Vietnam Antidepressants Sales Forecast 2018-2025 (K Units)
Table Central & South America Antidepressants Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Antidepressants Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Antidepressants Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Antidepressants Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Antidepressants Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Antidepressants Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Antidepressants Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Antidepressants Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Antidepressants Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Antidepressants Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Antidepressants Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Antidepressants Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

H Lundbeck、Astrazeneca、Eli Lilly and Company、Sun Pharmaceuticals、Pfizer Inc.、GlaxoSmithKline、Bristol-Myers Squibb Company、Johnson & Johnson、Merck、Sanofi

★調査レポート[抗うつ薬の世界市場動向・分析2018-2025] (コード:QYR8D00484)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗うつ薬の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆